Publicaciones en colaboración con investigadores/as de KU Leuven (44)

2026

  1. Asundexian for Secondary Stroke Prevention

    The New England journal of medicine, Vol. 394, Núm. 15, pp. 1467-1479

  2. CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in ischemic dilated CardioMyopathy: Prognostic implication of papillary muscles involvement

    Progress in Cardiovascular Diseases

  3. Corrigendum to ‘Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis’ (JHEP Reports 7 [2025] 101611) (JHEP Reports (2025) 7(12), (S2589555925002939), (10.1016/j.jhepr.2025.101611))

    JHEP Reports

  4. Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study

    Journal of Antimicrobial Chemotherapy, Vol. 81, Núm. 4

  5. Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD

    Journal of Hepatology, Vol. 84, Núm. 4, pp. 738-748

  6. Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team

    European Heart Journal: Acute Cardiovascular Care, Vol. 15, Núm. 2, pp. 151-161

  7. Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention

    European stroke journal, Vol. 11, Núm. 1

  8. Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle

    International Journal of Cardiology, Vol. 445

2025

  1. CarDiac magnEtic Resonance for prophylactic Implantable cardioVerter defibrillAtor ThErapy in Non-Dilated Left Ventricular Cardiomyopathy: A sub-study from the DERIVATE registry

    European Heart Journal Cardiovascular Imaging, Vol. 26, Núm. 7, pp. 1233-1241

  2. Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance

    International Journal of Cardiology, Vol. 419

  3. Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis

    Gut, Vol. 74, Núm. 8, pp. 1293-1307

  4. Hemorrhagic Infarction Does Not Worsen Functional Outcomes in Noncardioembolic Ischemic Stroke: Secondary Analysis From PACIFIC-STROKE

    Stroke, Vol. 56, Núm. 7, pp. 1730-1737

  5. Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

    The Lancet Infectious Diseases, Vol. 25, Núm. 11, pp. 1177-1188

  6. Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in RET Fusion-Positive NSCLC

    JTO Clinical and Research Reports, Vol. 6, Núm. 7

  7. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

    Journal of Hepatology, Vol. 82, Núm. 1, pp. 72-83

  8. Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis

    JHEP Reports, Vol. 7, Núm. 12

  9. Redefining the risk of major arrhythmic events in non-ischaemic cardiomyopathy: insights from the DERIVATE-NICM study

    European Heart Journal Cardiovascular Imaging, Vol. 26, Núm. 10, pp. 1609-1619

  10. Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial

    International Journal of Cardiology, Vol. 438

  11. State of the art management practices for liver glycogen storage disorders: Results from an international survey among metabolic centres

    Molecular Genetics and Metabolism, Vol. 145, Núm. 3

  12. Use of inhaled corticosteroids in bronchiectasis: Data from the European Bronchiectasis Registry (EMBARC)

    Thorax, Vol. 80, Núm. 6, pp. 358-368